Jaguar Health Inc (NASDAQ:JAGX)
| 4.70 Delayed Data As of 3:59pm ET |  +0.185 / +4.10%Today’s Change | 4.45 Today|||52-Week Range 66.75 | -27.96% Year-to-Date |
Latest JAGX News | Press Releases
No recent news for Jaguar Health Inc.
Today’s Trading
| Previous close | 4.51 |
| Today’s open | 4.49 |
| Day’s range | 4.49 - 4.74 |
| Volume | 2,557 |
| Average volume (3 months) | 124,357 |
| Market cap | $12.3M |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +60.80% |
| Earnings growth (this year) | +34.75% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -53.81% |
| P/E ratio | NM |
| Price/Sales | 10.73 |
| Price/Book | 0.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTIXProtagenic Therapeut... | 0.00 | 0.00% |
| KTRAKintara Therapeutics... | -0.34 | -4.93% |
| ---- | ||
| ADILAdial Pharmaceutical... | -0.02 | -5.45% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | April 11, 2023 |
| EPS forecast (this quarter) | -$9.75 |
| Annual revenue (last year) | $4.3M |
| Annual profit (last year) | -$52.6M |
| Net profit margin | -1,213.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
